| 101 |
Cognitive Impairment, P300, and Transforming Growth Factor β1 in Different Forms of Dementia |
2020 |
| 102 |
Depression and anxiety among patients with Parkinson’s disease: frequency, risk factors, and impact on quality of life |
2020 |
| 103 |
Depression and anxiety among patients with Parkinson’s disease: frequency, risk factors, and impact on quality of life |
2020 |
| 104 |
Depression and anxiety among patients with Parkinson’s disease: frequency, risk factors, and impact on quality of life |
2020 |
| 105 |
Effect of chronic nicotine consumption on motor cortical excitability: A transcranial magnetic stimulation study. |
2020 |
| 106 |
Effect of conditioning and test stimulus intensity on cortical excitability by using triad-conditioning Transcranial Magnetic Stimulation |
2020 |
| 107 |
Effect of psychotropic drugs on cortical excitability of patients with major depressive disorders: A transcranial magnetic stimulation study |
2020 |
| 108 |
Effect of psychotropic drugs on cortical excitability of patients with major depressive disorders: A transcranial magnetic stimulation study |
2020 |
| 109 |
Effect of psychotropic drugs on cortical excitability of patients with major depressive disorders: A transcranial magnetic stimulation study |
2020 |
| 110 |
Effect of psychotropic drugs on cortical excitability of patients with major depressive disorders: A transcranial magnetic stimulation study |
2020 |
هل لديك سؤال ؟
